Detalhe da pesquisa
1.
DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicity.
MAbs
; 11(8): 1402-1414, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31526159
2.
Anti-tumoral, anti-angiogenic and anti-metastatic efficacy of a tetravalent bispecific antibody (TAvi6) targeting VEGF-A and angiopoietin-2.
MAbs
; 8(3): 562-73, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26864324